ClinConnect ClinConnect Logo
Search / Trial NCT06433401

The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease

Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · May 23, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Congenital Heart Disease Adolescent Transition Care Nurses

ClinConnect Summary

This clinical trial is studying a new way to help teenagers with congenital heart disease, which means they were born with heart problems. The focus is on making sure these young people are ready to move from pediatric care (care for children) to adult care, which can be a big change. Researchers want to see if a special program called the developmental transition care model can improve how well these teens feel prepared for adult health care, how they manage their own health, and their satisfaction with the care they receive.

To participate in this study, teens need to be between 16 and 20 years old, have a diagnosis of congenital heart disease, and have been receiving care for at least a year. They should also be able to communicate in Turkish and not have any mental health issues that would make it hard to participate. Participants can expect to receive support and education to help them feel more comfortable and capable as they transition to adult care. This study aims to help improve the overall experience and health outcomes for these young patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Voluntarily agree to participate in the research
  • To be between the ages of 16-20,
  • Having a diagnosis of congenital heart disease,
  • Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted,
  • To be able to communicate in Turkish,
  • Not having any mental deficiency that may prevent communication
  • Exclusion Criteria:
  • Refusing to participate in the research,
  • Not being able to communicate in Turkish,
  • Not showing up regularly for follow-ups,
  • Having any mental disability that may prevent communication

About Ankara Yildirim Beyazıt University

Ankara Yıldırım Beyazıt University is a leading academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in healthcare and innovative research methodologies to conduct ethical and scientifically rigorous clinical studies. By fostering collaboration among multidisciplinary teams, Ankara Yıldırım Beyazıt University aims to contribute to the development of novel therapies and enhance patient care, while adhering to the highest standards of regulatory compliance and patient safety.

Locations

Ankara, Ankara Yenimahalle, Turkey

Patients applied

0 patients applied

Trial Officials

Tutku KIRÇI TEMİZ, PhD s.

Principal Investigator

Ankara Yildirim Beyazıt University

Evrim KIZILER, Asst.Prof.

Study Director

Ankara Yildirim Beyazıt University

Utku ARMAN ÖRÜN, Prof.Dr.

Study Director

Republic of Turkey Ministry of Health Ankara Etlik City Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported